Login / Signup
Jinbao Liu
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Leyi Yao
,
Qian Zhao
,
Ding Yan
,
Ziying Lei
,
Yali Hao
,
Jinghong Chen
,
Qian Xue
,
Xiaofen Li
,
Qingtian Huang
,
Daolin Tang
,
Q Ping Dou
,
Xin Chen
,
Jinbao Liu
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells.
Cancer biology & medicine
(2022)